- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[Strongyloides stercolaris]] by serology
- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[Strongyloides stercolaris]] by serology
- Primary goal: Safety (incidence of SAEs)
- Primary goal: Safety (incidence of SAEs)
- Secondary goals:
- Secondary goals:
- Effectiveness at 21 days and 1 year
- Effectiveness at 21 days and 1 [[year]]
- Genomic resistance
- Genomic resistance
- Sample size:
- Sample [[size]]: around 20k
- Target population: School based
- Epidemiologic conditions on the sites: T
- Nuestros objetivos:
- Nuestros objetivos:
- Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond
- Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond
- Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens
- Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens